Nemaura Medical Inc.
NMRD
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 0.00 | 3.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | 0.00 | 3.00K |
| Cost of Revenue | -- | -- | -- | 1.48M | 3.00K |
| Gross Profit | -- | -- | -- | -1.48M | 0.00 |
| SG&A Expenses | 1.25M | 1.56M | 1.51M | 1.27M | 1.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.54M | 2.05M | 2.06M | 3.31M | 1.63M |
| Operating Income | -1.54M | -2.05M | -2.06M | -3.31M | -1.62M |
| Income Before Tax | -2.16M | -1.20M | -2.60M | -4.68M | -1.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.16M | -1.20M | -2.60M | -4.68M | -1.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.16M | -1.20M | -2.60M | -4.68M | -1.72M |
| EBIT | -1.54M | -2.05M | -2.06M | -3.31M | -1.62M |
| EBITDA | -1.46M | -1.92M | -1.96M | -3.13M | -1.53M |
| EPS Basic | -0.07 | -0.04 | -0.09 | -0.17 | -0.07 |
| Normalized Basic EPS | -0.05 | -0.03 | -0.06 | -0.09 | -0.04 |
| EPS Diluted | -0.07 | -0.05 | -0.09 | -0.17 | -0.07 |
| Normalized Diluted EPS | -0.05 | -0.03 | -0.06 | -0.09 | -0.04 |
| Average Basic Shares Outstanding | 28.90M | 28.90M | 28.90M | 27.20M | 24.10M |
| Average Diluted Shares Outstanding | 28.90M | 28.90M | 28.90M | 27.20M | 24.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |